Glaukos (GKOS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
28 May, 2026Opening remarks and agenda
Meeting called to order by the Chair, with a virtual format to enhance stockholder participation.
Agenda and rules of conduct made available on the portal, with instructions for stockholder questions.
Board and executive committee updates
Board members and executive officers introduced, including representatives from the independent auditor.
Shareholder proposals
Three proposals presented: election of two Class II directors, advisory approval of executive compensation, and ratification of the independent auditor.
Board recommended approval of all proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Glaukos
- Record Q2 sales and raised guidance highlight strong glaucoma growth despite wider net loss.GKOS
Q2 20249 Jul 2026 - iDose launch drives growth, with broader coverage and new product milestones expected in 2025.GKOS
2024 Wells Fargo Healthcare Conference8 Jul 2026 - iDose adoption accelerates with reimbursement progress as pipeline and global competition advance.GKOS
Stephens 26th Annual Investment Conference | NASH20248 Jul 2026 - Record Q3 sales, raised guidance, and narrowed net loss highlight strong glaucoma growth.GKOS
Q3 20248 Jul 2026 - iDose's rapid growth and improving reimbursement position it as a key driver for near-term profitability.GKOS
Piper Sandler 36th Annual Healthcare Conference8 Jul 2026 - Strong revenue and margin growth, with iDose and Epioxa driving future expansion.GKOS
Stephens Annual Investment Conference8 Jul 2026 - iDose and Epioxa show strong growth amid evolving reimbursement and regulatory landscapes.GKOS
Truist Securities MedTech Conference 202616 Jun 2026 - Draft LCD challenges addressed, Epioxa launch strong, and pipeline innovation continues.GKOS
Jefferies Global Healthcare Conference 20263 Jun 2026 - Innovative therapies and robust pipeline fuel strong growth and market expansion.GKOS
46th Annual William Blair Growth Stock Conference2 Jun 2026